Brain Advance Access published online on May 4, 2005
Brain, doi:10.1093/brain/awh503
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Academic Neurology Unit, University of Sheffield, School of Medicine and Biomedical Sciences, Sheffield, UK
* To whom correspondence should be addressed. Familial amyotrophic lateral sclerosis (FALS) is caused, in 20% of cases, by mutations in the Cu/Zn superoxide dismutase gene (SOD1). Although motor neuron injury occurs through a toxic gain of function, the precise mechanism(s) remains unclear. Using an established NSC34 cellular model for SOD1-associated FALS, we investigated the effects of mutant SOD1 specifically in cells modelling the vulnerable cell population, the motor neurons, without contamination from non-neuronal cells present in CNS. Using gene expression profiling, 268 transcripts were differentially expressed in the presence of mutant human G93A SOD1. Of these, 197 were decreased, demonstrating that the presence of mutant SOD1 leads to a marked degree of transcriptional repression. Amongst these were a group of antioxidant response element (ARE) genes encoding phase II detoxifying enzymes and antioxidant response proteins (so-called programmed cell life genes), the expression of which is regulated by the transcription factor NRF2. We provide evidence that dysregulation of Nrf2 and the ARE, coupled with reduced pentose phosphate pathway activity and decreased generation of NADPH, represent significant and hitherto unrecognized components of the toxic gain of function of mutant SOD1. Other genes of interest significantly altered in the presence of mutant SOD1 include several previously implicated in neurodegeneration, as well as genes involved in protein degradation, the immune response, cell death/survival and the heat shock response. Preliminary studies on isolated motor neurons from SOD1-associated motor neuron disease cases suggest key genes are also differently expressed in the human disease.
Received May 26, 2004
Revised March 9, 2005
Accepted March 15, 2005
Article
Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS
2 Genome Instability Group, Department of Cancer Studies and Molecular Medicine, University of Leicester, Robert Kilpatrick Clinical Sciences Building, Leicester Royal Infirmary, Leicester, UK
3 Academic Neurology Unit, University of Sheffield, School of Medicine and Biomedical Sciences, Sheffield
Pamela J. Shaw, E-mail: Pamela.Shaw{at}sheffield.ac.uk
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. Bergemalm, K. Forsberg, P. A. Jonsson, K. S. Graffmo, T. Brannstrom, P. M. Andersen, H. Antti, and S. L. Marklund Changes in the Spinal Cord Proteome of an Amyotrophic Lateral Sclerosis Murine Model Determined by Differential In-gel Electrophoresis Mol. Cell. Proteomics, June 1, 2009; 8(6): 1306 - 1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Simpson, O. Hosny, S. B. Wharton, P. R. Heath, H. Holden, M. S. Fernando, F. Matthews, G. Forster, J. T. O'Brien, R. Barber, et al. Microarray RNA Expression Analysis of Cerebral White Matter Lesions Reveals Changes in Multiple Functional Pathways Stroke, February 1, 2009; 40(2): 369 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pitzer, C. Kruger, C. Plaas, F. Kirsch, T. Dittgen, R. Muller, R. Laage, S. Kastner, S. Suess, R. Spoelgen, et al. Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis Brain, December 1, 2008; 131(12): 3335 - 3347. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nishitoh, H. Kadowaki, A. Nagai, T. Maruyama, T. Yokota, H. Fukutomi, T. Noguchi, A. Matsuzawa, K. Takeda, and H. Ichijo ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1 Genes & Dev., June 1, 2008; 22(11): 1451 - 1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ferraiuolo, P. R. Heath, H. Holden, P. Kasher, J. Kirby, and P. J. Shaw Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS J. Neurosci., August 22, 2007; 27(34): 9201 - 9219. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pehar, M. R. Vargas, K. M. Robinson, P. Cassina, P. J. Diaz-Amarilla, T. M. Hagen, R. Radi, L. Barbeito, and J. S. Beckman Mitochondrial Superoxide Production and Nuclear Factor Erythroid 2-Related Factor 2 Activation in p75 Neurotrophin Receptor-Induced Motor Neuron Apoptosis J. Neurosci., July 18, 2007; 27(29): 7777 - 7785. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Zona, M. Pieri, and I. Carunchio Voltage-Dependent Sodium Channels in Spinal Cord Motor Neurons Display Rapid Recovery From Fast Inactivation in a Mouse Model of Amyotrophic Lateral Sclerosis J Neurophysiol, December 1, 2006; 96(6): 3314 - 3322. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Wood-Allum, S. C. Barber, J. Kirby, P. Heath, H. Holden, R. Mead, A. Higginbottom, S. Allen, T. Beaujeux, S. E. Alexson, et al. Impairment of mitochondrial anti-oxidant defence in SOD1-related motor neuron injury and amelioration by ebselen Brain, July 1, 2006; 129(7): 1693 - 1709. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhai, H. Lin, R. Canete-Soler, and W. W. Schlaepfer HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS Hum. Mol. Genet., September 15, 2005; 14(18): 2629 - 2640. [Abstract] [Full Text] [PDF] |
||||






